Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07331987 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Probiotics for Anxiety Depression

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Mar 1, 2026 to Jun 15, 2026 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Mar 1, 2026 to Jun 15, 2026
    • Site details revised
  2. Secondary endpoints: details revised at 2 of 2 entriesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized, double-blind, placebo-controlled study will enroll 60 individuals with mild-to-moderate anxiety depression. Following a 3-month intervention and a 1-month follow-up period, the study aims to: 1) evaluate the efficacy of probiotics by comparing anxiety, depression, and sleep scores to baseline; and 2) investigate the safety and underlying mechanisms by analyzing changes in serum biomarkers, gut microbiota, and related metabolites.
Trial Details
NCT Number NCT07331987
Lead Sponsor Moon (Guangzhou) Biotechnology Co., Ltd.
Conditions Anxiety Depression
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov